Insider Transactions in Q3 2025 at C4 Therapeutics, Inc. (CCCC)
Insider Transaction List (Q3 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Sep 18
2025
|
Kendra Adams Chief Financial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
2,775
-1.68%
|
$8,325
$3.32 P/Share
|
|
Sep 18
2025
|
Kendra Adams Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
6,250
+3.65%
|
-
|
|
Jul 10
2025
|
Leonard Reyno Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,382
-4.25%
|
$7,382
$1.99 P/Share
|
|
Jul 01
2025
|
Donna Roy Grogan Director |
BUY
Grant, award, or other acquisition
|
Direct |
9,609
+15.62%
|
$9,609
$1.51 P/Share
|
|
Jul 01
2025
|
Kenneth Carl Anderson Director |
BUY
Grant, award, or other acquisition
|
Direct |
7,616
+5.33%
|
$7,616
$1.51 P/Share
|